291638
Telepharmacy brown bag medication management clinics for rural veterans
Methods: A pilot project began in Fiscal Year (FY) 2012 at three rural VHA Community Based Outpatient Clinics (CBOC) in Maine. The project has goals of 1) training pharmacy residents and sixth-year pharmacy students to conduct MR/PE via CVT with rural patients, and 2) address polypharmacy issues with rural Veterans. The project is ongoing for FY13.
Results Feedback from patients has been very positive. Virtually all patients have indicated comfort with CVT format and believe they received good care. Semi-structured interviews were conducted at the end of FY12 with staff. Overall impressions were positive: decreased patient burden (drive-time), patient education, and reduction of medication side effects. Some conflicting opinions were gleaned regarding the perceived benefit to staff (workload burden, role-confusion). Individual clinics were tasked with identifying/recruiting patients for CVT visits. These various methods had mixed results.
Conclusions: These results indicate that this innovative approach to ME/PE has much positive potential to affect a population with particular complexities. Increased efforts and resources have been dedicated for FY13. Lessons-learned include improved staff communication and systematic efforts at patient recruitment.
Planning of health education strategies, interventions, and programs
Learning Objectives:
Explain the unique challenges of medication reconciliation with rural Veterans.
Discuss the advantages and possible barriers to CVT technology programs.
Describe the ways that CVT programs can be effectively evaluated.
Keywords: Veterans' Health, Rural Health Care
Qualified on the content I am responsible for because: I serve as Program Analyst for the Veterans Rural Health Resource Center – Eastern Region (VRHRC-ER) and I am the lead analyst on this quality improvement project.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.